🇺🇸 FDA
Patent

US 12098138

Substituted pyridinyl azetidinone derivatives for use in treating cancer and other diseases

granted A61PA61P35/00

Quick answer

US patent 12098138 (Substituted pyridinyl azetidinone derivatives for use in treating cancer and other diseases) held by The Board of Regents of the University of Texas System expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P35/00